Clinical Trial Update: Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada [Phase 3]

View source ↗

Summary

Phase 3 long-term study to assess safety and tolerability of valbenazine in participants with chorea associated with Huntington disease in Canada; the trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Valbenazine (valbenazine)

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Chorea, Huntington | Phase 3 | Status: ENROLLING_BY_INVITATION